#United Kingdom #MatOrtho #ReCerf #Hip Resurfacing #Leatherhead

A New Era in Orthopedic Surgery: The ReCerf® Hip Resurfacing Arthroplasty

In a significant milestone for orthopedic medicine, MatOrtho, a pioneering UK-based company specializing in hip and knee replacement devices, has announced that its innovative ReCerf® Hip Resurfacing Arthroplasty is now the world's first all-ceramic hip resurfacing system to secure regulatory approval. This marks a transformative leap forward for joint replacement technology, changing the lives of patients and their medical journeys.

Approval by TGA in Australia

The Therapeutic Goods Administration (TGA) of Australia granted approval to the ReCerf system, which is a groundbreaking achievement within the sphere of orthopedic surgery. Oriol Millet-Lopez, interim CEO of MatOrtho, expressed great pride in this accomplishment. He described the ReCerf as the product of years of dedication and innovative research aimed at enhancing patient outcomes. Notably, the early performance results have been highly encouraging, leading industry experts to believe that it may redefine the standards of hip replacement on a global scale.

Since its introduction in September 2018, over 1,200 patients have received the ReCerf device. Impressively, the system has exhibited lower rates of surgical revisions compared to traditional hip replacements. Data shows a remarkably low revision rate of just 0.3% at three years, as reported in the 2024 Annual Report of the Australian Orthopaedic Association National Joint Replacement Registry. Patients, both young and active, have experienced fewer complications and have returned to their sporting pursuits without significant limitations.

The Benefits of All-Ceramic Technology

With the ReCerf system's all-ceramic 'delta' composition, concerns over metal implants are alleviated. This innovative design allows surgeons to preserve more of the patient's natural hip, potentially eliminating the need for a traditional stemmed total hip replacement. Mike Tuke, the founder of MatOrtho, emphasized that this system caters not just to the prevalent needs of hip resurfacing but also inspires confidence among both surgeons and patients alike.

Future Implications and Broader Acceptance

The TGA's approval signals the beginning of a new journey for MatOrtho as it seeks to expand the ReCerf's accessibility. Continuous collaboration with the Australia Prosthesis List Advisory Committee (PLAC) is in place to ensure that ReCerf can be added to the upcoming prosthesis list. Furthermore, strategies to secure regulatory approvals in other essential markets are underway to extend the benefits of this innovative technology to a broader range of patients in need.

Looking ahead, the ReCerf Hip Resurfacing Arthroplasty is expected to contribute significantly to the evolution of joint replacement techniques. With over a decade of painstaking research outlined in its development, MatOrtho remains committed to advancing orthopedic practices with an unwavering focus on patient-centred care.

For more insights into the ReCerf Hip Resurfacing System and MatOrtho's relentless pursuit of innovation in orthopedics, visit www.recerf.com and discover how they are shaping the future of joint replacement surgery.

About MatOrtho

MatOrtho stands at the forefront of orthopedic innovation, dedicated to developing cutting-edge devices that enhance patient outcomes. By setting new benchmarks in hip and knee joint replacements, their ongoing commitment reflects a conscientious approach to surgical excellence.

[1] MatOrtho Limited. Data on file 01 December 2024.
[2] Lewis PL et al. Hip, Knee and Shoulder Arthroplasty 2024 Annual Report, Australian Orthopaedic Association National Joint Replacement Registry, AOA Adelaide, South Australia. 2024.